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Abstract
One of the many functions of skin is to protect the organism against a wide range of patho-
gens. Antimicrobial peptides (AMPs) produced by the skin epithelium provide an effective
chemical shield against microbial pathogens. However, whereas antibacterial/antifungal ac-
tivities of AMPs have been extensively characterized, much less is known regarding their
wound healing-modulatory properties. By using an in vitro re-epithelialisation assay employ-
ing special cell-culture inserts, we detected that a derivative of the frog-skin AMP esculen-
tin-1a, named esculentin-1a(1-21)NH2, significantly stimulates migration of immortalized
human keratinocytes (HaCaT cells) over a wide range of peptide concentrations (0.025–
4 μM), and this notably more efficiently than human cathelicidin (LL-37). This activity is pre-
served in primary human epidermal keratinocytes. By using appropriate inhibitors and an
enzyme-linked immunosorbent assay we found that the peptide-induced cell migration in-
volves activation of the epidermal growth factor receptor and STAT3 protein. These results
suggest that esculentin-1a(1-21)NH2 now deserves to be tested in standard wound healing
assays as a novel candidate promoter of skin re-epithelialisation. The established ability of
esculentin-1a(1-21)NH2 to kill microbes without harming mammalian cells, namely its high
anti-Pseudomonal activity, makes this AMP a particularly attractive candidate wound heal-
ing promoter, especially in the management of chronic, often Pseudomonas-infected,
skin ulcers.
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Introduction
Gene-encoded antimicrobial peptides (AMPs) are produced by all living unicellular and multi-
cellular organisms; they serve key roles in innate immune defences and possess a wide spec-
trum of activities against bacteria, fungi and viruses [1–3]. Despite their enormous structural
diversity, most AMPs share a net positive charge at neutral pH, a high content of hydrophobic
residues and an amphipathic character [4,5]. In animals, they are predominantly expressed in
the skin and the mucosal surfaces (e.g. the mouth, the eyes, the genito-urinary tract and the
gut) where they form a chemical barrier between host tissues and the environment [6–8]. In
addition, they are also produced by circulating immune cells such as leukocytes [9,10].
The skin is the environmentally most exposed organ and provides first-line defence against
penetrating infectious microorganisms. In mammals, including humans, epidermal keratino-
cytes produce AMPs (e.g., the cathelicidin LL-37 and the beta-defensins hBD2 and hBD3)
which are stored along with lipids within secretory granules called lamellar bodies [11–17]. Fol-
lowing skin wounding, infection and inflammation, keratinocyte lamellar bodies release their
content of hydrophobic products and AMPs into intercellular spaces forming a chemical barri-
er against water loss and microbial attack [18–20]. Furthermore, infiltrating immune cells such
as neutrophils and natural killer cells also contribute to the pool of AMPs in the skin [21–23].
Apart from their direct antimicrobial activity, mammalian AMPs display additional protec-
tive functions which have led to their classification as "host-defence peptides" [24]. These func-
tions include the capability to stimulate the host immune system while suppressing the
inflammatory response, as well as the ability to promote tissue repair through stimulation of
epithelial cell migration [25–28].
In this respect, frog skin-derived peptides, including AMPs, may be of particular interest
[29]. As a stratified squamous epithelium, the epidermis of adult frogs is histologically quite
similar to that of humans [30]. Amphibian skin has a tissue repair and a defence system that
enables wound healing without scarring [31] and contains a huge arsenal of pharmacological
agents, including multiple neuropeptides and AMPs [32]. The AMPs are mainly stored within
granules of the dermal glands controlled by the sympathetic nervous system and are secreted
in response to stress or physical injury by a holocrine-type mechanism [33–35]. All frog species
synthesize a unique set of AMPs, constituting families of 2–100 closely related members
[36,37]. Over the past two decades, in vitro and in vivo experiments have demonstrated that
frog-skin AMPs play a crucial role in maintaining the equilibrium of the natural microbial
flora and that their synthesis is induced by microorganisms [38–40].
Recently, we have focused on the short variant of the frog-skin AMP esculentin-1a, esculen-
tin-1a(1-21)NH2 [Esc(1-21), GIFSKLAGKKIKNLLISGLKG-NH2]. This consists of the first 20
amino acids of esculentin-1a (isolated from the skin of Pelophylax lessonae/ridibundus, former-
ly known as Rana esculenta) plus a glycinamide residue at its C-terminus [34,41–43]. This pep-
tide possesses a wide spectrum of antimicrobial activity with demonstrated efficacy against
both planktonic and biofilm forms of the Gram-negative bacterium Pseudomonas aeruginosa.
P. aeruginosa is clinically important as a major pathogenic microorganism that causes various
types of infections, such as those associated with the lungs, ocular surface, middle ear and skin
wounds [44,45]. Mode of action studies have shown that membrane-perturbing activity is the
major mechanism responsible for the killing action of Esc(1-21) on both phenotypes of this
pathogen, thus limiting the induction of microbial resistance [46]. Resistance to cationic pep-
tides whose mechanism of action is based on non-specific interaction with the anionic phos-
pholipids of the bacterial membrane is considered difficult since it would involve drastic
changes of the membrane lipid composition and potentially compromising the pathogen’s sur-
vival [46]. Note that compared to the extensively studied human skin AMP, LL-37 [47–50], the
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frog-skin AMP derived Esc(1-21) peptide may be clinically more attractive, for example due to
the ability to preserve antimicrobial activity in biological fluids [51], and to its documented fast
killing activity against a major human pathogen associated with chronic skin ulcers, P. aerugi-
nosa [46,52]. However, it is as yet unknown whether Esc(1-21) has any wound healing-
promoting properties.
As a first screening step towards exploring whether Esc(1-21) peptide is able to promote re-
epithelialisation in the human system, we studied its ability to stimulate, in vitro, the migratory
activity of human immortalized and primary epidermal keratinocytes in a modified scratch
assay, and compared the results with those of LL-37. In order to establish whether a stereospe-
cific mechanism based on the interaction with a chiral target was involved, the all-D-enantio-
mer of Esc(1-21) (containing all amino acid residues in the D configuration) was used.
Furthermore, as already found for LL-37 [53], the involvement of the epidermal growth factor
receptor (EGFR) and STAT3 protein in the peptide-induced signaling pathway controlling mi-
gration of HaCaT cells was also investigated.
Materials and Methods
Materials
Hoechst 33258, 3(4,5-dimethylthiazol-2yl)2,5-diphenyltetrazolium bromide (MTT), AG1478,
mitomycin C; phalloidin-fluorescein isothiocyanate, LL-37 were from Sigma-Aldrich (St. Luis,
MO); GM6001 was from Calbiochem (Merk Millipore, Germany).
Frog skin peptides
Synthetic all-L and all-D Esc(1-21) peptides as well as the rhodamine-labeled all-L Esc(1-21) were
purchased from Selleck Chemicals (Houston, TX, USA). Briefly, each peptide was assembled by
step-wise solid-phase synthesis using a standard F-moc strategy and purified by RP-HPLC on a
semipreparative C18-bonded silica column (Kromasyl, 5 μm, 100 Å, 25 cm × 4.6 mm) using a
gradient of acetonitrile in 0.1% aqueous trifluoroacetic acid (from 25 to 100% in 30 min) at a flow
rate of 1.0 ml/min. The product was obtained by lyophilization of the appropriate fraction. Ana-
lytical RP-HPLC indicated a purity>98%. The molecular mass was verified by using MALDI--
TOF Voyager DE (Applied Biosystems, Carlsbad, CA, USA) as previously described [54].
Cell culture
The extensively characterized human immortalized keratinocyte cell line, HaCaT (ATCC,
USA) [55] was used in most assays. Cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), glutamine (4 mM)
and 0.05 mg/ml gentamycin, at 37°C and 5% CO2, in 25-cm
2 flasks.
Cultures of primary human epidermal keratinocytes (NHKs), derived from neonatal fore-
skins (at passage 4) were maintained in Medium 154 (Invitrogen, Life Sciences, Milan, Italy)
supplemented with Human Keratinocyte Growth Supplement (HKGS, Invitrogen) plus antibi-
otics (100 μg/ml penicillin/streptomycin), 4 mM glutamine and Ca2+ (0.07 mM) in a humidi-
fied atmosphere containing 5% CO2 at 37°C, as previously described [56]. All treatments were
performed in the same medium without HKGS to avoid any interference with the
peptide's activity.
Cell toxicity assay
The toxic effect of the investigated peptides on HaCaT cells was evaluated using the MTT col-
orimetric method [57]. MTT is a tetrazolium salt which is reduced to a formazan product by
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mitochondrial reductases giving a purple color. The intensity of the color is directly propor-
tional to the number of metabolically-active cells. Keratinocytes were plated in triplicate wells
of a microtiter plate, at 4 x 104 cells/well in DMEM supplemented with 4 mM glutamine
(DMEMg) and 2% FBS without antibiotic. After overnight incubation at 37°C and 5% CO2 at-
mosphere, the medium was replaced with 100 μl fresh serum-free DMEMg containing the pep-
tides at different concentrations. The plate was incubated for 2h or 24h at 37°C and 5% CO2
atmosphere. Then, DMEMg was removed and replaced with Hank’s buffer (136 mMNaCl; 4.2
mMNa2HPO4; 4.4 mM KH2PO4; 5.4 mM KCl; 4.1 mM NaHCO3, pH 7.2, supplemented with
20 mMD-glucose) containing 0.5 mg/ml MTT. After 4 h incubation, the formazan crystals
were dissolved by adding 100 μl of acidified isopropanol according to [57], and absorbance of
each well was measured at 570 nm using a microplate reader (Infinite M200; Tecan, Salzburg,
Austria).
In vitro cell migration assay
The peptides' ability to stimulate migration of epithelial cells, in vitro, was studied according to
a modified scratch assay, as described in [58–60]. Briefly, HaCaT cells (40,000) suspended in
DMEMg supplemented with 10% FBS were seeded on each side of an ibidi culture insert for
live cell analysis (Ibidi, Munich, Germany). Inserts were placed into wells of a 12-wells plate
and incubated at 37°C and 5% CO2 to allow cells grow to confluence. Afterwards, inserts were
removed with sterile tweezers to create a cell-free area (pseudo-"wound") of approximately
500 μm, whose re-epithelialisation by migrating HaCaT keratinocytes was quantitatively as-
sessed; 1 ml serum-free DMEMg supplemented or not with the peptide at different concentra-
tions was added. Cells were allowed to migrate in an appropriate incubator.
In the case of NHKs, 35,000 cells suspended in supplemented Medium 154 were seeded on
each side of the ibidi culture insert. After overnight incubation at 37°C and 5% CO2 the medi-
um was replaced with fresh medium without HKGS for 6 h. Afterwards, inserts were removed
as described above and 1 ml of medium supplemented or not with the peptide at different con-
centrations was added. Primary keratinocytes were allowed to migrate in an appropriate incu-
bator, as for HaCaT cells. All experiments were run three times in triplicates.
At different time intervals, fields of the pseudo-"wound" area were visualized under an in-
verted microscope (Olympus CKX41) at x 4 magnification and photographed with a Color
View II digital camera. The percentage of cell-covered area at each time was determined by
WIMASIS Image Analysis program. The migration speed was evaluated according to
WIMASIS' instructions.
Pseudo-“wound” closure assays with HaCaT cells were also conducted by pre-treating these
cells with 3 μMmitomycin C [60,61], 25 μMGM6001 [62,63] or 0.2 μMAG1478 inhibitor
[53,64] in order to assess the contribution of cell proliferation, metalloproteinase activity or
EGFR signaling in the peptide-induced migration of keratinocytes.
Enzyme-linked immunosorbent assay (ELISA)
Phosphorylation of STAT-3 by all-L Esc(1-21) was analyzed by an ELISA assay according to
the manufacturer's protocol (Phospho Tyr 705-Stat3 ELISA, RayBiotech, Norcross, GA, USA).
Briefly, subconfluent HaCaT keratinocytes (about 1x 106 cells in a 6-cm dish plate) were treat-
ed or not with 0.25 μM peptide in DMEMg for 20 min. Afterwards, cells were lysed with lysis
buffer supplemented with proteases and phosphatases inhibitors. Samples were centrifuged
at 12,600 g and the supernatants were added to wells of a microtiter plate coated with anti-
STAT3 antibody. After 2.5 h incubation at room temperature, the supernatant was discarded,
the wells were washed and biotinylated anti-STAT3 (Tyr 705) antibody was added to each well,
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for 1h at room temperature, to detect only phosphorylated STAT3 (Tyr 705). After washing
away unbound antibody, horseradish peroxidase conjugated streptavidin was added to each
well for 1h. The wells were washed again and a substrate (3,3’,5,5’-tetramethylbenzidine) solu-
tion was added. Color developed in proportion to the amount of bound phosphorylated
STAT3 (Tyr 705). The reaction was stopped after 30 min incubation and the intensity of the
color was measured with a microplate reader (Infinite M200; Tecan, Salzburg, Austria) at
450 nm.
Fluorescence microscopy
HaCaT cells (40,000) were seeded on coverslips for 24h in DMEMg supplemented with 10%
FBS, at 37°C and 5% CO2. After 24h, cells were washed with phosphate buffered saline (PBS)
and treated with rhodamine-labeled Esc(1-21) (4 μM in serum-free DMEMg) at 37°C and 5%
CO2. After different time intervals (30 min and 24h), samples were washed with PBS and fixed
with 3.7% formaldehyde for 10 min at +4°C. Afterwards, they were washed with PBS and
stained with 2 μg/ml Hoechst 33258 for 10 min at room temperature [65]. The coverslips were
placed on a glass slide with buffered glycerol and visualized under a fluorescence microscope
(Keyence Biozero-8000 Microscope; Keyence Corporation, Osaka, Japan). Hoechst and rhoda-
mine-labeled Esc(1-21) were visualized using laser wavelength of 360 and 560 nm respectively.
All images were taken using objective lens of 60X and zoom.
Statistical analyses
Data were collected and pooled from three independent experiments. Quantitative data are ex-
pressed as the mean ± SEM. Statistical analysis was performed using Student's t test or two-way
analysis of variance (ANOVA) with PRISM software (GraphPad, San Diego, CA). Differences
were considered to be statistically significant for a p value< 0.05.
Results
Esc(1-21) enantiomers do not exhibit significant toxicity towards HaCaT
keratinocytes
In order to assess, first, the toxicity of Esc(1-21) enantiomers, the number of metabolically-ac-
tive HaCaT cells after a short (2h) and long (24h) treatment interval was studied. Neither pep-
tide showed any marked reduction in the number of metabolically-active keratinocytes after a
2h incubation at concentrations of 2 to 64 μM, and the difference between the two was not sta-
tistically significant (Fig 1A). In contrast, after a 24h interval, only the all-L peptide showed
slight toxicity at 32 μM and 64 μM (Fig 1B), causing approximately a 20% reduction in the per-
centage of metabolically-active cells compared to the all-D Esc(1-21) (p<0.001). Note that LL-
37 led to complete inhibition of HaCaT cells metabolism at 200 μg/ml (~44 μM) [66]. This
shows that only the all-L Esc(1-21) has limited toxicity towards HaCaT cells, but that this is sig-
nificantly lower than that reported for LL-37 [66].
All-L Esc(1-21), but not its all-D enantiomer, stimulates HaCaT cell
migration
To evaluate, next, the ability of different concentrations of both isomers to promote cell migra-
tion, an in vitro cell migration assay was performed by means of special plastic inserts and a
modified scratch assay design [55] to create a 500 μmwide gap within a monolayer of HaCaT
cells. The all-L peptide promoted complete coverage of the pseudo-"wound" field in about
9–12h with a bell-shaped dose-response curve (Fig 2A). The optimal concentration allowing
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gap closure was 0.25 μM (Fig 2A and 2B). In contrast, no statistically significant difference in
the cell-covered area was measured between the all-D Esc(1-21)-treated samples and the vehi-
cle (medium)-treated control group (Fig 2B and 2C). That the all-D enantiomer did not signifi-
cantly promote re-epithelialisation of the pseudo-"wound" area in vitro suggests
stereospecificity of the mechanism of all-L Esc(1-21)-induced keratinocyte migration.
All-L Esc(1-21) also stimulates “wound” re-epithelialisation by primary
human epidermal keratinocytes in vitro
As the biological properties of cell lines differ from those of primary cells, the pseudo-"wound"
healing activity of all-L Esc(1-21) was also tested on monolayers of primary human epidermal
keratinocytes. Importantly, the peptide was found to promote re-epithelialisation of the
"wound" gap area within 24h at a concentration range between 4 μM and 10 μM (Fig 3A). The
most effective peptide dosage (10 μM) completely restored integrity of the NHK monolayer
within 20 h (Fig 3B).
LL-37 stimulates HaCaT cell migration at a narrower concentration
range and less efficiently than all-L Esc(1-21)
In order to compare all-L Esc(1-21) with the most extensively investigated human skin AMP,
the cells' migratory activity caused by LL-37 was subsequently analyzed (Fig 4A). LL-37 is a
well-known human AMP with a demonstrated wound healing effect [67] and ability to pro-
mote the migration of several different mammalian cell types, including keratinocytes [68] and
corneal epithelial cells [69]. However, LL-37 activities have not previously been evaluated
under the present experimental conditions, i.e. using the culture insert scratch assay modifica-
tion employed here [55].
In agreement with a published report [53], LL-37 was able to stimulate the closure of the
pseudo-"wound" field within 12h at an optimal concentration of 0.25 μM (Fig 4A and 4B).
Fig 1. Effect of all-L and all-D Esc(1-21) peptides at different concentrations on the number of
metabolically-active HaCaT cells after a short (A) or long (B) term treatment. Cells were plated in wells
of a microtiter plate, at 4x104 cells/well. After overnight incubation at 37°C in a 5% CO2 atmosphere, the
medium was replaced with 100 μl fresh medium supplemented with the peptides at different concentrations.
After 2h (A) or 24h (B) of peptide treatment, cell viability was determined by the MTT reduction to insoluble
formazan (see Materials and Methods for additional information). Cell viability is expressed as percentage
with respect to the vehicle-treated control cells. Data points represent the mean of triplicate samples ± SEM.
The level of statistical significance between all-L and all-D peptides is indicated as follows: ***, p<0.001.
doi:10.1371/journal.pone.0128663.g001
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Importantly, however, the percentage of the re-epithelialized area calculated at different time
intervals following peptide addition was higher for all-L Esc(1-21) (Fig 2A), with a front speed
migration equal to 20 μm/h, compared to 17 μm/h estimated for LL-37. No statistically signifi-
cant difference was obtained between vehicle-treated samples and those incubated with LL-37
at concentrations lower than 0.25 μM (Fig 4A). Furthermore, the cell migration activity was
completely inhibited by LL-37 at concentrations of 1 μM and above (Fig 4B). Therefore, under
Fig 2. Effect of all-L and all-D Esc(1-21) on the closure of a pseudo-"wound" field produced in a monolayer of HaCaT cells. HaCaT cells were seeded
in each side of an ibidi culture insert and grown to confluence. Afterwards, they were treated with all-L (A) or all-D (C) peptide at different concentrations, as
indicated. Cells were photographed at the time of insert removal (0 h) and examined for cell migration after 3, 6, 9 and 12h from peptide addition. The
percentage of cell-covered area at each time point is reported on the y-axis. Control (Ctrl) is given by vehicle-treated cells. All data are the mean of three
independent experiments ± SEM. The levels of statistical significance between Ctrl and peptide-treated samples are indicated as follows: *, p<0.05; **,
p<0.01;***, p<0.001. (B): micrographs showing representative results of pseudo-"wound" closure induced upon treatment of keratinocytes with 0.25 μM all-L
Esc(1-21) or all-D Esc(1-21) with respect to the Ctrl sample.
doi:10.1371/journal.pone.0128663.g002
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the current assay conditions, LL-37 is less efficient than all-L Esc(1-21) in promoting migration
of HaCaT cells in vitro and exhibits a narrower “therapeutic” window.
All-L Esc(1-21) primarily promotes keratinocyte migration in vitro
Next, we examined potential mechanisms that may underlie the re-epithelialisation-promoting
properties of all-L Esc(1-21). In order to abrogate cell proliferation, HaCaT cells were pre-treat-
ed with the cell proliferation blocker, mitomycin C. As shown in Fig 5, this did not significantly
delay re-epithelialisation of the pseudo-“wound” area in monolayer culture produced by either
0.25 μM all-L Esc(1-21) or LL-37, within 12h. When the activity of mitomycin C was checked
independently, it was noted that this treatment switched the morphology of HaCaT cells to a
round cell shape, a recognized stop signal for keratinocyte cell division [70], without influenc-
ing their viability (data not shown).
Fig 3. Effect of all-L Esc(1-21) on the closure of a pseudo-"wound" field produced in a monolayer of
primary human keratinocytes. (A): two monolayers of primary keratinocytes separated by a defined
distance were treated with the peptide at different concentrations, as indicated. Cells were photographed at
the time of insert removal (0 h) and examined for cell migration after 15, 20 and 24h from peptide addition.
The percentage of cell-covered area at each time point is reported on the y-axis. Control (Ctrl) is given by
vehicle-treated cells. All data are the mean of three independent experiments ± SEM. The levels of statistical
significance between Ctrl and peptide-treated samples are indicated as follows: *, p<0.5; ***, p<0.001. (B):
micrographs showing representative results upon treatment of primary keratinocytes with all-L Esc(1-21)
(4 μM and 10 μM) with respect to the Ctrl sample. The black line marks off the cell-free area in the peptide-
treated samples after 15 and 20 h. No cell-free area was noted in samples treated with 10 μM peptide after 20
and 24h.
doi:10.1371/journal.pone.0128663.g003
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Furthermore, compared to vehicle-treated HaCaT cells (Fig 6A), typical morphological
changes associated with a migratory phenotype [71,72] were detected in HaCaT cells upon
treatment with all-L Esc(1-21). Notably, these became visible through the formation of cyto-
plasmic protrusions developing into filopodial extensions (Fig 6B), quite similar to the pheno-
typic effects that have been reported for LL-37 [68]. Overall, these observations suggest that the
re-epithelialisation-promoting properties of all-L Esc(1-21) primarily result from its ability to
stimulate keratinocyte migration, rather than keratinocyte proliferation.
Fig 4. Effect of LL-37 on the closure of a pseudo-"wound" field produced in a monolayer of HaCaT
cells. (A): two monolayers of HaCaT cells separated by a defined distance were treated with LL-37 at
different concentrations, as indicated. Cells were photographed at the time of insert removal (0 h) and
examined for cell migration after 3, 6, 9 and 12h from peptide addition. The percentage of cell-covered area at
each time point is reported on the y-axis. Control (Ctrl) is given by vehicle-treated cells. All data are the mean
of three independent experiments ± SEM. The level of statistical significance between Ctrl and peptide-
treated samples is indicated as follows: ***, p<0.001. (B): micrographs showing representative results upon
treatment of keratinocytes with LL-37 (0.25 μM, 1 μM and 4 μM) with respect to the Ctrl sample.
doi:10.1371/journal.pone.0128663.g004
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Fig 5. Effect of mitomycin C (Mito) on the peptides-mediated closure of a pseudo-"wound" field
produced in a HaCaT cells monolayer. (A) After removal of the ibidi culture insert, HaCaT cell monolayers
were pre-incubated or not with 3 μMMito for 30 min and subsequently treated with 0.25 μM all-L Esc(1-21) or
LL-37. Cells incubated with medium served as control (Ctrl). Samples were photographed at different time
intervals, as indicated in the legends to Figs 2 and 4, and the percentage of cell-covered area was calculated
and reported on the y-axis. All data are the mean of three independent experiments ± SEM. No statistical
significance was found between samples treated with the peptide alone or pre-incubated with Mito.
doi:10.1371/journal.pone.0128663.g005
Fig 6. Effect of all-L Esc(1-21) on the phenotype of HaCaT cells.Cells (150,000) were seeded on a glass
coverslip and treated or not with 0.25 μM peptide in DMEMg for 12h at 37°C and 5%CO2. Afterwards,
samples were washed three times with PBS and fixed with 3.7% formaldehyde for 10 min at +4°C. Then, they
were permeabilized with 0.1% Triton X-100 for 10 min at room temperature and stained with phalloidin-
fluorescein isothiocyanate (40 μM in PBS) for 30 min at room temperature, to visualize the cytoskeleton. The
nuclei were stained by adding 50 μl of Hoechst 33258 (2 μg/ml) for 10 min at room temperature. The
coverslips were mounted on slides and observed under a fluorescent microscope (KOZOOPTICS XJF800)
at 40 x magnification and photographed with a Color View II digital camera. (A): vehicle-treated control cells;
(B) peptide-treated cells. Insets represent the magnification of the image portion indicated by the white frame.
rows indicate filopodial formation.
doi:10.1371/journal.pone.0128663.g006
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All-L Esc(1-21) stimulates migration of HaCaT keratinocytes in a EGFR-
dependent manner
To explore whether EGFR played a similar role in the signaling transduction cascade control-
ling the Esc(1-21)-stimulated migration of cells as it had been reported for LL-37 [53], HaCaT
cells were pre-incubated with the tyrosine kinase inhibitor of EGFR, AG1478 [64], and were
subsequently exposed to the all-L enantiomer. As illustrated in Fig 7, the peptide-promoted mi-
gration of HaCaT cells was significantly impaired by inhibiting EGFR-mediated signaling, sug-
gesting that Esc(1-21)-stimulated re-epithelialisation requires EGFR activation.
Since metalloproteinases have been shown to cleave membrane-anchored EGFR ligands
and to be involved in EGFR trans-activation [73], the effect of the metalloproteinase inhibitor
GM6001 [62,63] was evaluated on the peptide-induced keratinocyte migration. Pretreatment
of HaCaT cells with GM6001 indeed counteracted the Esc(1-21)-stimulated re-epithelialisation
of the pseudo-"wound" area in keratinocyte monolayer (Fig 7) indicating a contribution of
metalloproteinase activity in the peptide-induced stimulation of keratinocytes migration.
Hereafter, we determined whether the intracellular pathway involving the activation of
STAT3 protein that has previously been demonstrated for LL-37 [53], is also implicated in Esc
(1-21)-stimulated re-epithelialisation. To this end, an ELISA assay was performed to assess the
level of STAT3 phosphorylation at Tyr 705 (active form) [74], after a 20 min incubation of
HaCaT cells with the maximally effective concentration of all-L Esc(1-21) (0.25 μM). Keratino-
cytes treated with 0.25 μM LL-37 were included as a positive control.
This showed that the amount of phospho-STAT3(Tyr 705) was significantly higher in Esc
(1-21)-treated cells compared to vehicle-treated controls (p< 0.001) and similar to that in-
duced by LL-37 (Fig 8). This indicates that Esc(1-21)-promoted HaCaT cell migration, again
similar to LL-37 [53], also involves STAT3 phosphorylation.
All-L Esc(1-21) efficiently penetrates into the cytoplasm of HaCaT cells
As this may affect the biological activities of this AMP in vivo, we finally investigated whether
Esc(1-21) remains localized on the surface of cultured keratinocytes or is internalized into the
Fig 7. Effect of AG1478 and GM6001 inhibitors on the all-L Esc(1-21)-mediated closure of a pseudo-
"wound" field produced in a HaCaT cells monolayer. After removal of the ibidi culture insert, HaCaT cell
monolayers were pre-incubated with 0.2 μMAG1478 for 15 min or with 25 μMGM6001 for 30 min and
subsequently treated with 0.25 μM all-L Esc(1-21). Cells incubated with medium served as control (Ctrl).
Samples were photographed at different time intervals, as indicated in the legend to Fig 2, and the
percentage of cell-covered area was calculated and reported on the y-axis. All data are the mean of three
independent experiments ± SEM. The levels of statistical significance between inhibitor-pretreated groups
and samples treated with the peptide alone are indicated as follows:*, p<0.05; **, p< 0.01; ***, p< 0.001.
doi:10.1371/journal.pone.0128663.g007
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cytoplasm or nucleus. HaCaT cells were exposed to rhodamine-labeled Esc(1-21) and stained
with Hoechst 33258 dye so as to permit the differential visualization of the AMP and cell nu-
clei, respectively, by fluorescence microscopy. This revealed that the fluorescently labelled pep-
tide was distributed inside the HaCaT cells and concentrated mainly at the nuclear periphery
within 30 min after administration to the culture medium (Fig 9 left panels), without entering
into the nucleus even 24h after its addition to the cells (Fig 9 right panels). Similar results were
obtained with another class of amphibian skin AMPs, i.e. the temporins [55], suggesting that
after membrane binding and indirect activation of EGFR, Esc(1-21) and likely other frog skin
linear peptides are internalized into the keratinocyte cytoplasm.
Discussion
Here, we provide the first evidence that a peptide fragment derived from the frog-skin AMP
esculentin-1a, esculentin-1a(1-21)NH2, promotes the re-epithelialisation of surrogate scratch
“wounds” by human keratinocytes in vitro, notably both in HaCaT cells and in primary epider-
mal keratinocytes, and this more effectively and at much lower cell toxicity than the prototypic
human skin AMP, LL-37. Importantly, migration of HaCaT cells upon addition of Esc(1-21)
occurs over a wider peptide concentration range (from 0.025 to 4 μM) compared to LL-37
which completely loses activity at 1 and 4 μM (Fig 4). Furthermore, although 0.25 μM is the op-
timal concentration for both AMPs, the cell migration rate induced by Esc(1-21) is higher than
that of LL-37.
This introduces Esc(1-21) as a new candidate wound healing promoter. Our study is in gen-
eral agreement with earlier reports that other frog skin-derived peptides can promote epithelial
cells migration [29,55] and wound healing in murine models, namely through the release of
transforming growth factor β1 [75]. However, the current study is the first to show that an
esculentin-1a-derived peptide promotes keratinocyte migration via an EGFR-dependent
signaling pathway.
Mechanistically, we show that the re-epithelialisation promoted by Esc(1-21) is stereospecif-
ic, possibly based on a stereoselective interaction with chiral targets, such as proteins [25,76].
Importantly, cell proliferation does not significantly contribute to the re-epithelialisation-pro-
moting effect of Esc(1-21), which appears to be mainly dependent on the stimulation of
Fig 8. Phosphorylation of STAT3 by all-L Esc(1-21). About 1 x 106 keratinocytes were stimulated with
0.25 μM all-L Esc(1-21) or LL-37 for 20 min. Control (Ctrl) was given by vehicle-treated cells. Cells were
harvested into lysis buffer and phospho-STAT3 (Tyr 705) was evaluated by performing an ELISA assay (see
Materials and methods). All data are the mean of three independent experiments ± SEM. The level of
statistical significance between peptide-treated samples and Ctrl is indicated as follows: ***, p < 0.001.
doi:10.1371/journal.pone.0128663.g008
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keratinocyte migration. As previously shown for LL-37 [53], the promotion of keratinocyte mi-
gration by Esc(1-21) requires activation of an EGFR signaling pathway. Note that erbB4 recep-
tor (another member of the EGFR family), whose activation can be hampered by the EGFR
inhibitor employed here (AG1478) [77–79], is not expressed in human keratinocytes and
HaCaT cells [80,81]. Our in vitro assays have also indicated a contribution of metalloproteinase
activity in the Esc(1-21)-induced migration of keratinocytes. This raises the question whether
the re-epithelialisation-promoting activities of this AMP require cleavage of membrane-bound
EGFR ligands and/or receptor trans-activation by metalloproteinases.
Furthermore, one of the signaling events implicates tyrosine phosphorylation and activation
of STAT3 protein [82]. This is in line with the previous demonstration that EGFR-induced cell
migration is mediated predominantly by the STAT-pathway in keratinocytes and that STAT3
plays an essential role for skin remodeling and wound healing [82,83].
Fig 9. Images of HaCaT cells treated with rhodamine-labeled all-L Esc(1-21) at different times (30 min
and 24h). Panels A and A' show bright field images. Black arrows indicate keratinocytes. B and B' show the
Hoechst fluorescence signal which indicates the nuclei position. Panels C and C' show the distribution of the
rhodamine-labeled Esc(1-21). Red fluorescence is not detectable at the level of nuclei (white arrows), but
rather in the cytoplasm and mainly concentrated at the nuclei periphery, already after a short incubation time
(C). Panels D and D' show the overlay of the two fluorescent probes. All images are z section images taken
from the mid-cell height. All bars indicate 10 μm.
doi:10.1371/journal.pone.0128663.g009
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Yet, multiple additional molecular mechanisms might participate in the enhanced migra-
tion of keratinocytes after exposure to Esc(1-21), such as the PI3K/Akt signaling pathway, like-
ly mediated not only through activation of EGFR but also through the induction of G-protein-
coupled receptor FPRL-1 [68]. Therefore, additional experiments are needed to clarify the
exact intracellular signaling events that govern Esc(1-21)-promoted keratinocyte migration. In
this context, it is interesting to note that our data also show that Esc(1-21) quickly translocates
into the cytoplasm via yet to be discovered mechanisms, possibly upon interaction with the cell
membrane and activation of EGFR; this may trigger further signaling pathways controlling ker-
atinocyte migration and efficient re-epithelialisation. However, it can currently not be excluded
that this peptide is also capable of integrating into the cell membrane (without causing cytotox-
icity) and to subsequently enter into the cytosol, or that it can be internalized via endocytosis.
The current work also encourages one to re-evaluate the potential overall benefits of frog
skin-derived AMPs in clinical medicine [28]. Skin secretions from many species of Anura
(frogs and toads), especially those belonging to the Hylidae and Ranidae family, are among the
most abundant sources for biologically-active peptides, including AMPs, presently numbering
more than a thousand [84]. Esc(1-21) in particular has been recently identified as a derivative
of the longer peptide esculentin-1a, with clinically attractive features for a potential new thera-
peutic agent. Remarkably, Esc(1-21) has the capability to preserve antibacterial activity even at
high salt concentrations [46] as well as in the presence of serum and tears [51]. This is in sharp
contrast to the properties of the key human AMPs, hBD-2 and LL-37, which completely lose
their antimicrobial efficacy at the high ionic strength (e.g., 100 mMmonovalent cations) found
at many body sites [85], such as the sputum, airway surfaces and serum/plasma [86–90]. Fur-
thermore, their antimicrobial activity is drastically reduced in biological fluids [91].
Although these mammalian AMPs certainly function as powerful microbicidal agents at the
high concentration (mg/ml) present in the phagolysosomes of neutrophils, they probably act as
immunomodulators at those physiological setting e.g. inflammatory sites, generally containing
high levels of mono and bivalent cations, where they are released by degranulation at lower
concentrations [47,90]. This would explain the lack of antibacterial activity of these AMPs
when tested, in vitro, under conditions (i.e. peptide concentrations and culture media) that bet-
ter mimic those encountered in their natural environment [88,91–94]. In contrast, the estimat-
ed concentration of peptides in the skin mucus of resting (non-stressed) frogs is within the
concentration range that shows antimicrobial activity in vitro [95], supporting the notion that
AMPs produced in amphibian skin provide remarkable chemical weapons against skin patho-
gens [96]. This may be especially important for newly metamorphosed frogs in which the adap-
tive immune system is still immature [35,97]. Another advantageous feature of Esc(1-21)
compared to classical mammalian AMPs is that, given its short sequence, it may be possible to
produce this AMP more economically. Finally, we should recall that Esc(1-21) is significantly
less cytotoxic than LL-37 toward HaCaT cells, in agreement with literature data showing that
human cathelicidins become harmful to mammalian cells, when used at high concentrations
[98].
Given the complexity of the recognized individual stages of skin wound healing in vivo [99],
it is evident that even the re-epithelialisation component of skin wound healing alone can be
very incompletely reproduced in vitro, i.e. in the absence of fibroblasts, immunocytes, and
functional perfusion and innervation. Therefore, the current results need to be followed-up,
next, at the preclinical research level in more complex human skin assays, using for example
the punch-in-a-punch design of organ-cultured full-thickness human skin [29]. However, the
ibidi culture insert system used here [55] provides an objective and highly reproducible initial
experimental screening tool for the quantitative evaluation of human keratinocyte migration
and its manipulation by candidate wound healing promoters. This simplified in vitro-surrogate
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assay for re-epithelialisation may be preferable over the classical scratch assay method, where
the gap width created with a plastic pipette tip is highly dependent on the pressure applied and
where detached cells can easily form clumps at the edges of the scratch, affecting the rate of cell
migration, thus giving potentially confounding results.
In summary, here we provide the first evidence that Esc(1-21) significantly and more effec-
tively than LL-37 stimulates human keratinocyte migration in an in vitro assay, likely in man-
ner that involves activation of EGFR and STAT3 protein. The established ability of Esc(1-21)
to kill microbes without harming mammalian cells, namely its high anti-Pseudomonal activity
also in physiologically relevant conditions [46,51] makes this short-sized AMP a particularly
attractive candidate wound healing promoter, especially in the management of chronic, often
Pseudomonas-super-infected, human skin ulcers [52,100].
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